Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2016-01-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Critical Care Optimized Pediatric and Neonatal Quantitative Neuromonitoring
NCT06726408
Evaluation of EEG Power Spectrum in Patients With Traumatic Coma
NCT06321146
Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses
NCT02082873
Using EEG to Study Coma in the Neurocritical Care Unit
NCT01897194
Continuous EEG Randomized Trial in Adults
NCT03129438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intensivists will evaluate:
* simmetry,
* sedation level,
* seizures activities and
* artefact on continuous cEEG/qEEG tracings. The same tracings will be blindly reviewed by a certified neurophysiologist (using the app). The neurophysiologist evaluation will be considered as "reference".
The results of the evaluation will be compared (intensivists vs. neurophysiologist) in order to understand if the intensivists are able to adequately identify the pathological findings.
The study period will be:
* before a formal training
* after a formal training by neurophysiologist in order to understand if the training is able to improve the intensivists performance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
qEEG patients
All the patients with continuous EEG (\>24 hours) in the two study units
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients in coma after a traumatic/vascular event
* Admitted to neurointensive care and
* Recorded with continuous EEG for clinical reasons
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Papa Giovanni XXIII Hospital
OTHER
Azienda Ospedaliera San Gerardo di Monza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Giuseppe Citerio
NeuroIntensive Care Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Citerio, MD
Role: PRINCIPAL_INVESTIGATOR
Università Milano Bicocca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliera Papa Giovanni Xxiii
Bergamo, , Italy
Azienda Ospedaliera San Gerardo
Monza, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EEG2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.